With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13484-40-7,1-(2-Methoxyethyl)piperazine,as a common compound, the synthetic route is as follows.
4-({6-[ 1 -(tert-Butoxycarbonyl)- 1 H-indol-2-yl]pyrazin-2-yl}amino)-3- methoxybenzoic acid (20.0 mg, 0.04 mmol), l-(2-methoxyethyl)piperazine (10.4 mg, 0.07 mmol), TBTU (18.1 mg, 0.06 mmol) and TEA (7.5 muL, 0.06 mmol) in DMF ( 1 mL) were shaken at ambient temperature for 48h after which the temperature was raised to 1400C for 6h, let to ambient temperature and purified using preparative HPLC system A followed by system E. Yield 0.4 mg (2%). HPLC 100%, RT: 1.854 (10-97% MeCN over 3min). MS 487 (M+H)+., 13484-40-7
The synthetic route of 13484-40-7 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; BIOVITRUM AB (PUBL); WO2007/147874; (2007); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics